# Title
6alpha-hydroxylation O
of O
taurochenodeoxycholic B-Chemical
acid I-Chemical
and O
lithocholic B-Chemical
acid I-Chemical
by O
CYP3A4 B-Gene
in O
human B-Species
liver O
microsomes. O

# Abstract
The O
aim O
of O
the O
present O
study O
was O
to O
identify O
the O
enzymes O
in O
human B-Species
liver O
catalyzing O
hydroxylations O
of O
bile B-Chemical
acids. I-Chemical
Fourteen O
recombinant O
expressed O
cytochrome O
P450 B-Gene
(CYP) O
enzymes, O
human B-Species
liver O
microsomes O
from O
different O
donors, O
and O
selective O
cytochrome O
P450 B-Gene
inhibitors O
were O
used O
to O
study O
the O
hydroxylation O
of O
taurochenodeoxycholic B-Chemical
acid I-Chemical
and O
lithocholic B-Chemical
acid. I-Chemical
Recombinant O
expressed O
CYP3A4 B-Gene
was O
the O
only O
enzyme O
that O
was O
active O
towards O
these O
bile B-Chemical
acids I-Chemical
and O
the O
enzyme O
catalyzed O
an O
efficient O
6alpha-hydroxylation O
of O
both O
taurochenodeoxycholic B-Chemical
acid I-Chemical
and O
lithocholic B-Chemical
acid. I-Chemical
The O
Vmax O
for O
6alpha-hydroxylation O
of O
taurochenodeoxycholic B-Chemical
acid I-Chemical
by O
CYP3A4 B-Gene
was O
18.2 O
nmol O
nmol O
P450 B-Gene
min O
and O
the O
apparent O
Km O
was O
90 O
microM. O
Cytochrome B-Gene
b5 I-Gene
was O
required O
for O
maximal O
activity. O
Human B-Species
liver O
microsomes O
from O
10 O
different O
donors, O
in O
which O
different O
P450 B-Gene
marker O
activities O
had O
been O
determined, O
were O
separately O
incubated O
with O
taurochenodeoxycholic B-Chemical
acid I-Chemical
and O
lithocholic B-Chemical
acid. I-Chemical
A O
strong O
correlation O
was O
found O
between O
6alpha-hydroxylation O
of O
taurochenodeoxycholic B-Chemical
acid, I-Chemical
CYP3A B-Gene
levels O
(r2=0.97) O
and O
testosterone B-Chemical
6beta-hydroxylation O
(r2=0.9). O
There O
was O
also O
a O
strong O
correlation O
between O
6alpha-hydroxylation O
of O
lithocholic B-Chemical
acid, I-Chemical
CYP3A B-Gene
levels O
and O
testosterone B-Chemical
6beta-hydroxylation O
(r2=0.7). O
Troleandomycin, B-Chemical
a O
selective O
inhibitor O
of O
CYP3A B-Gene
enzymes, O
inhibited O
6alpha-hydroxylation O
of O
taurochenodeoxycholic B-Chemical
acid I-Chemical
almost O
completely O
at O
a O
10 O
microM O
concentration. O
Other O
inhibitors, O
such O
as O
alpha-naphthoflavone, B-Chemical
sulfaphenazole B-Chemical
and O
tranylcypromine B-Chemical
had O
very O
little O
or O
no O
effect O
on O
the O
activity. O
The O
apparent O
Km O
for O
6alpha-hydroxylation O
of O
taurochenodeoxycholic B-Chemical
by O
human B-Species
liver O
microsomes O
was O
high O
(716 O
microM). O
This O
might O
give O
an O
explanation O
for O
the O
limited O
formation O
of O
6alpha-hydroxylated B-Chemical
bile I-Chemical
acids I-Chemical
in O
healthy O
humans. B-Species
From O
the O
present O
results, O
it O
can O
be O
concluded O
that O
CYP3A4 B-Gene
is O
active O
in O
the O
6alpha-hydroxylation O
of O
both O
taurochenodeoxycholic B-Chemical
acid I-Chemical
and O
lithocholic B-Chemical
acid I-Chemical
in O
human B-Species
liver. O